Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Factors Related to Functional Recovery Using Brain Imaging of Stroke Patients

Completed

Conditions: Stroke

Interventions: Behavioral: Data acquisition of functional abilities

First Posted Date: 2018-08-15

Last Posted Date: 2020-09-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 73

Registration Number: NCT03632070

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Phase 1

Not yet recruiting

Conditions: Refractory Pediatric Solid Tumor
Relapsed Pediatric Solid Tumor

Interventions: Drug: Pazopanib
Drug: Ifosfamide
Drug: Carboplatin
Drug: Etoposide

First Posted Date: 2018-08-14

Last Posted Date: 2018-09-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 46

Registration Number: NCT03628131

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Phase 2

Completed

Conditions: Glioblastoma, Adult
EGFR Amplification

Interventions: Drug: GC1118

First Posted Date: 2018-08-07

Last Posted Date: 2023-05-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 13

Registration Number: NCT03618667

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Phase 2

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2018-08-06

Last Posted Date: 2018-08-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 46

Registration Number: NCT03616691

Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma

Phase 2

Conditions: Salivary Duct Carcinoma

Interventions: Drug: nanoxel
Drug: herzuma

First Posted Date: 2018-08-03

Last Posted Date: 2022-01-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 41

Registration Number: NCT03614364

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)

Conditions: Cardiac Event
Sleep Disorder
Cardiac Arrythmias
Cardiac Implantable Electronic Device

Interventions: Diagnostic Test: Device interrogation

First Posted Date: 2018-08-03

Last Posted Date: 2021-06-30

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 600

Registration Number: NCT03614377

Locations: 🇰🇷
Chungbuk National University Hospital, Chungju, Korea, Republic of
🇰🇷
Samsung Changwon Medical Center, Changwon, Korea, Republic of
🇰🇷
Yeongnam University Medical Center, Daegu, Korea, Republic of

and more 11 locations

Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer

Phase 2

Conditions: Small Cell Lung Cancer

Interventions: Drug: Durvalumab

First Posted Date: 2018-07-13

Last Posted Date: 2020-03-02

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 51

Registration Number: NCT03585998

Locations: 🇰🇷
Samsung Medical Center, Seoul, MA, Korea, Republic of

The Prediction for Postoperative Pain

Not Applicable

Completed

Conditions: Analgesics
Pain, Postoperative
Analgesia, Patient-Controlled
Nociceptive Pain

Interventions: Device: surgical pleth index

First Posted Date: 2018-07-12

Last Posted Date: 2018-10-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 53

Registration Number: NCT03585088

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

Phase 2

Conditions: Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)

Interventions: Drug: Edoxaban
Drug: Enoxaparin

First Posted Date: 2018-06-26

Last Posted Date: 2018-06-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT03570281

Locations: 🇰🇷
Department of Neurology, Samsung Medical Center, Seoul, Korea, Republic of

Effect of the Mobile Self-input Tool of Incentive Spirometer (RCT)

Not Applicable

Completed

Conditions: Gastrectomy

Interventions: Other: Alarm
Other: Nurse's dashboard

First Posted Date: 2018-06-26

Last Posted Date: 2018-07-17

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 44

Registration Number: NCT03569332

Locations: 🇰🇷
Samsung Medical Center, Seoul, Gangnam, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy